IP Verse

Ferring patent opposition analysis

Get complete Patent Opposition Report for Ferring

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Ferring

Explore patent oppositions filed by Ferring against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3278809Safe Desmopressin AdministrationALLERGANAug 20, 2020
EP2854790Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture MediaARES TRADINGMay 14, 2019
EP2381923Safe Desmopressin AdministrationACERUS PHARMACEUTICALS USAMay 1, 2019
EP2164877The Puro-Dhfr Quadrifunctional Marker And Its Use In Protein ProductionMERCK SERONOSep 4, 2018
EP2442821Safe Desmopressin AdministrationACERUS PHARMACEUTICALS USAMar 12, 2018

Latest patents of Ferring opposed by its competitors

Explore Ferring's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3784210Mar 13, 2024Topical Pharmaceutical Composition For Treatment Of Anal Fissures And Hemorrhoids1
EP3222272Nov 3, 2021Pharmaceutical Composition2
EP3144318Sep 23, 2020Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation1
EP2292252Aug 7, 2019Unitary Combination Of Fsh And Hcg1
EP2424503Jul 5, 2017Composition For The Treatment Of Prostate Cancer1
EP3045471Mar 29, 2017Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation1

Top competitors of Ferring